Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07181720	CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors	suspended	Phase 1	90	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Sep 11, 2026	clinicaltrials
NCT04683653	Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer	suspended	Phase 1 / Phase 2	100	University of ChicagoOTHER	1	Sep 10, 2026	clinicaltrials